Robert Williams, Jr. Sells 3,000,000 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 3,000,000 shares of Aveanna Healthcare stock in a transaction on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total transaction of $24,030,000.00. Following the transaction, the insider directly owned 190,130 shares in the company, valued at $1,522,941.30. This represents a 94.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Aveanna Healthcare Stock Up 3.7%

Shares of AVAH stock traded up $0.33 on Thursday, hitting $9.19. The stock had a trading volume of 1,002,532 shares, compared to its average volume of 1,480,237. The business has a 50 day moving average of $7.25 and a 200 day moving average of $7.56. The stock has a market cap of $2.00 billion, a price-to-earnings ratio of 7.83, a price-to-earnings-growth ratio of 0.88 and a beta of 1.89. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.73 and a 12-month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The business had revenue of $647.91 million for the quarter, compared to analysts’ expectations of $613.22 million. The firm’s revenue for the quarter was up 15.9% on a year-over-year basis. As a group, analysts expect that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on AVAH shares. Raymond James Financial raised Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price for the company in a report on Friday, March 20th. Barclays decreased their target price on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a research report on Monday, May 18th. Truist Financial boosted their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a report on Wednesday, May 20th. Weiss Ratings downgraded shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. Finally, BMO Capital Markets lowered their price objective on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $10.50.

Institutional Investors Weigh In On Aveanna Healthcare

Large investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd raised its stake in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after acquiring an additional 2,400 shares during the period. Summit Securities Group LLC bought a new position in Aveanna Healthcare during the first quarter worth about $53,000. Quantbot Technologies LP purchased a new position in shares of Aveanna Healthcare in the second quarter worth about $43,000. EverSource Wealth Advisors LLC raised its position in shares of Aveanna Healthcare by 88,100.0% in the third quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock valued at $102,000 after purchasing an additional 11,453 shares during the period. Finally, Entropy Technologies LP bought a new stake in shares of Aveanna Healthcare in the third quarter valued at approximately $107,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.